Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY).
Sakamoto T, Shimura M, Kitano S, Ohji M, Ogura Y, Yamashita H, Suzaki M, Mori K, Ohashi Y, Yap PS, Kaneko T, Ishibashi T; MERCURY Study Group.
Sakamoto T, et al.
Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):477-487. doi: 10.1007/s00417-021-05308-8. Epub 2021 Sep 3.
Graefes Arch Clin Exp Ophthalmol. 2022.
PMID: 34477927
Free PMC article.
PURPOSE: The MERCURY study aimed to evaluate the effects on visual acuity and psychological symptoms, and safety, of ranibizumab and subsequent treatment in patients with diabetic macular oedema (DME) and impaired visual acuity (VA). ...Other treatment …
PURPOSE: The MERCURY study aimed to evaluate the effects on visual acuity and psychological symptoms, and safety, of ranibizum …